HomeCompareTLGT vs PLD

TLGT vs PLD: Dividend Comparison 2026

TLGT yields 27377.52% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLGT wins by $1.188659204665963e+21M in total portfolio value
10 years
TLGT
TLGT
● Live price
27377.52%
Share price
$0.17
Annual div
$47.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.188659204665963e+21M
Annual income
$1,180,179,287,020,189,700,000,000,000.00
Full TLGT calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TLGT vs PLD

📍 TLGT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLGTPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLGT + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLGT pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLGT
Annual income on $10K today (after 15% tax)
$2,327,089.34/yr
After 10yr DRIP, annual income (after tax)
$1,003,152,393,967,161,200,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, TLGT beats the other by $1,003,152,393,967,161,200,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLGT + PLD for your $10,000?

TLGT: 50%PLD: 50%
100% PLD50/50100% TLGT
Portfolio after 10yr
$594329602332981460992.00M
Annual income
$590,089,643,510,094,850,000,000,000.00/yr
Blended yield
99.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TLGT
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLGT buys
0
PLD buys
0
No recent congressional trades found for TLGT or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLGTPLD
Forward yield27377.52%3.10%
Annual dividend / share$47.50$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1.188659204665963e+21M$5.91M
Annual income after 10y$1,180,179,287,020,189,700,000,000,000.00$4,750,725.19
Total dividends collected$1.188100965028857e+21M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: TLGT vs PLD ($10,000, DRIP)

YearTLGT PortfolioTLGT Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$2,748,452$2,737,752.16$11,241$540.96+$2.74MTLGT
2$706,172,699$703,231,854.70$13,019$991.13+$706.16MTLGT
3$169,619,770,362$168,864,165,574.45$15,801$1,870.97+$169619.75MTLGT
4$38,088,480,331,187$37,906,987,176,899.56$20,609$3,701.21+$38088480.31MTLGT
5$7,995,983,294,959,344$7,955,228,621,004,974.00$29,919$7,867.97+$7995983294.93MTLGT
6$1,569,355,212,688,684,500$1,560,799,510,563,078,100.00$50,631$18,617.74+$1569355212688.63MTLGT
7$287,973,521,392,263,700,000$286,294,311,314,686,770,000.00$105,528$51,352.20+$287973521392263.63MTLGT
8$49,405,729,451,981,220,000,000$49,097,597,784,091,490,000,000.00$287,364$174,449.42+$49405729451981216.00MTLGT
9$7,925,156,678,292,761,000,000,000$7,872,292,547,779,143,000,000,000.00$1,081,760$774,280.77+$7925156678292761600.00MTLGT
10$1,188,659,204,665,962,900,000,000,000$1,180,179,287,020,189,700,000,000,000.00$5,908,209$4,750,725.19+$1.188659204665963e+21MTLGT

TLGT vs PLD: Complete Analysis 2026

TLGTStock

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.

Full TLGT Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TLGT vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLGT vs SCHDTLGT vs JEPITLGT vs OTLGT vs KOTLGT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.